A forum for researchers, students and applicants in the field of cyclodextrin technology
The malignancy of colorectal cancer is connected with inflammation and tumor-associated macrophages (TAMs), but effective therapeutics for colorectal cancer are
Water-soluble seven hexylimidazolium modified amphiphilic cyclodextrin (AMCD) selectively combined with ATP to form a stable 1 : 1 inclusion complex
2021 China International BioPharma Conference will be held on September 19th-21th in China Medical City Convention and Exhibition Center, Taizhou China.
Kazia Therapeutics Limited, an Australian oncology-focused biotechnology company shared top-line final data from its phase I study of Cantrixil (TRX-E-002-1)
Midatech Pharma PLC, an R&D biotechnology company focused on improving the bio‐delivery and biodistribution of medicines, announced encouraging headline results
In this study, antibody–supermolecule conjugates, consisting of a tumor-specific antibody and acid-labile polyrotaxane containing methylated b-cyclodextrin (Me-PRX), were designed to
Introduction: Antimicrobial resistance is one of the major scourges for healthcare worldwide, therefore novel investigational approaches are needed to potentiate and
Approval Based on the CANDOR and EQUULEUS Studies in Patients With Relapsed/Refractory Multiple Myeloma Amgen today announced the U.S. Food and
Transdermal drug delivery offers advantages over nonparenteral routes such as bypassing first-pass metabolism and facile administration. Mammalian skin, however, functions
This article reviews the controlled release of current anticancer drugs based on cyclodextrins as a “flexible switch”, and discusses the
